|
Jul 1
|
Ikonisys SA: Suspension of Trading of Shares on Euronext Growth Paris Until the Publication of the 2024 Annual Report
|
|
Dec 31
|
Ikonisys Finalized the Acquisition of Hospitex with the Issuance of 2M New Shares to ETH Scientific
|
|
Oct 14
|
Ikonisys Completed a Capital Increase Through a Private Placement
|
|
Oct 10
|
Ikonisys Announces That Hospitex International Won the Public Tender of the Prestigious U.O.C. Pathological Anatomy of Enna in Italy
|
|
May 15
|
Ikonisys: Hospitex to Obtain International Patent for the BLOCKfast Cyto-Inclusion Kit
|
|
Nov 30
|
Ikonisys to Acquire Hospitex International and Become an Integrated Cancer Diagnostic Leader
|
|
Oct 31
|
Ikonisys and Biocare Medical Forge Alliance: Amplifying Global FISH Diagnostics with Advanced Fluorescent Scopes
|
|
Oct 30
|
Ikonisys publishes its 2023 half-year financial results and reviews its operational and strategic deployments
|